{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T15:50:52Z","timestamp":1791993052717,"version":"4.4.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T00:00:00Z","timestamp":1752451200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP17im0110605h"],"award-info":[{"award-number":["JP17im0110605h"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019384","name":"Kitasato University Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019384","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012835","name":"Toho University","doi-asserted-by":"publisher","award":["M201-R"],"award-info":[{"award-number":["M201-R"]}],"id":[{"id":"10.13039\/100012835","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012835","name":"Toho University","doi-asserted-by":"publisher","award":["K201"],"award-info":[{"award-number":["K201"]}],"id":[{"id":"10.13039\/100012835","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["RG\/20\/6\/35095"],"award-info":[{"award-number":["RG\/20\/6\/35095"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["PG\/19\/55\/34545"],"award-info":[{"award-number":["PG\/19\/55\/34545"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.jpet.2025.103652","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T11:52:35Z","timestamp":1751457155000},"page":"103652","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Pharmacological study of the safety, efficacy, and potential of M201-A on paroxysmal and persistent atrial fibrillation"],"prefix":"10.1016","volume":"392","author":[{"given":"Noboru","family":"Kaneko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Godfrey L.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher M.","family":"Loughrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuko","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kengo","family":"Kusano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9535-5327","authenticated-orcid":false,"given":"Yuko","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoyuki","family":"Otani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Toda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayley","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3229-5424","authenticated-orcid":false,"given":"Ana","family":"Da Silva Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Dobi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyanka","family":"Saxena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3387-2123","authenticated-orcid":false,"given":"Patrick B.","family":"Mark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Shinozaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuichi","family":"Kambayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Riddell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elspeth B.","family":"Elliott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2816-2285","authenticated-orcid":false,"given":"Charlotte S.","family":"McCarroll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2416-5865","authenticated-orcid":false,"given":"Takeshi","family":"Kitai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6241-7985","authenticated-orcid":false,"given":"Tomoko","family":"Hasunuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Shimamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiya","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9538-6879","authenticated-orcid":false,"given":"Masahiko","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Migaku","family":"Kikuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8260-833X","authenticated-orcid":false,"given":"Shigeru","family":"Toyoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2765-5165","authenticated-orcid":false,"given":"Tetsuya","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichiro","family":"Kumagai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isao","family":"Taguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4861-7259","authenticated-orcid":false,"given":"Atsushi","family":"Sugiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8601-6200","authenticated-orcid":false,"given":"Yasuki","family":"Kihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiko","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Kumagai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunio","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.jpet.2025.103652_bib1","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1161\/CIR.0000000000000659","article-title":"Heart disease and stroke statistics\u20142019 update: a report from the American Heart Association","volume":"139","author":"Benjamin","year":"2019","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.jpet.2025.103652_bib2","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"},{"issue":"12","key":"10.1016\/j.jpet.2025.103652_bib3","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1056\/NEJM199103213241201","article-title":"Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial","volume":"324","author":"Echt","year":"1991","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.jpet.2025.103652_bib4","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/0735-1097(92)90267-Q","article-title":"The Cardiac Arrhythmia Suppression Trial: first CAST \u2026 then CAST-II","volume":"19","author":"Greene","year":"1992","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.jpet.2025.103652_bib5","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1056\/NEJM199207233270403","article-title":"Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction","volume":"327","year":"1992","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.jpet.2025.103652_bib6","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S0002-9149(98)00006-X","article-title":"Mortality in the Survival With ORal D-Sotalol (SWORD) trial: why did patients die?","volume":"81","author":"Pratt","year":"1998","journal-title":"Am J Cardiol"},{"issue":"38","key":"10.1016\/j.jpet.2025.103652_bib7","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","article-title":"2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"37","author":"Kirchhof","year":"2016","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.jpet.2025.103652_bib8","first-page":"751","article-title":"Atrial fibrillation and heart failure: a review of the intersection of two cardiac epidemics","volume":"6","author":"Lee Park","year":"2013","journal-title":"J Atr Fibrillation"},{"issue":"18","key":"10.1016\/j.jpet.2025.103652_bib9","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1161\/CIRCULATIONAHA.108.821306","article-title":"Atrial fibrillation and heart failure: treatment considerations for a dual epidemic","volume":"119","author":"Anter","year":"2009","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.jpet.2025.103652_bib10","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nrd3682","article-title":"Novel molecular targets for atrial fibrillation therapy","volume":"11","author":"Dobrev","year":"2012","journal-title":"Nat Rev Drug Discov"},{"issue":"2","key":"10.1016\/j.jpet.2025.103652_bib11","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/FJC.0b013e31816c4325","article-title":"Inward rectifier potassium currents as a target for atrial fibrillation therapy","volume":"52","author":"Ehrlich","year":"2008","journal-title":"J Cardiovasc Pharmacol"},{"issue":"4","key":"10.1016\/j.jpet.2025.103652_bib12","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/ddr.430330406","article-title":"New 1,4-benzothiazepine derivative, K201, demonstrates cardioprotective effects against sudden cardiac cell death and intracellular calcium blocking action","volume":"33","author":"Kaneko","year":"1994","journal-title":"Drug Dev Res"},{"issue":"3","key":"10.1016\/j.jpet.2025.103652_bib13","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0021-5198(19)53280-2","article-title":"Effects of a novel cardioprotective drug, JTV-519, on membrane currents of guinea pig ventricular myocytes","volume":"79","author":"Kimura","year":"1999","journal-title":"Jpn J Pharmacol"},{"issue":"6","key":"10.1016\/j.jpet.2025.103652_bib14","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1007\/s002100000230","article-title":"Effects of JTV-519, a novel anti-ischaemic drug, on the delayed rectifier K+ current in guinea-pig ventricular myocytes","volume":"361","author":"Kiriyama","year":"2000","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"7","key":"10.1016\/j.jpet.2025.103652_bib15","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1038\/sj.bjp.0703713","article-title":"Inhibitory effects of JTV-519, a novel cardioprotective drug, on potassium currents and experimental atrial fibrillation in guinea-pig hearts","volume":"131","author":"Nakaya","year":"2000","journal-title":"Br J Pharmacol"},{"issue":"8","key":"10.1016\/j.jpet.2025.103652_bib16","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1046\/j.1540-8167.2003.03050.x","article-title":"Antiarrhythmic effects of JTV-519, a novel cardioprotective drug, on atrial fibrillation\/flutter in a canine sterile pericarditis model","volume":"14","author":"Kumagai","year":"2003","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"5668","key":"10.1016\/j.jpet.2025.103652_bib17","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1126\/science.1094301","article-title":"Protection from cardiac arrhythmia through ryanodine receptor-stabilizing protein calstabin2","volume":"304","author":"Wehrens","year":"2004","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.jpet.2025.103652_bib18","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.cardiores.2007.06.014","article-title":"K201 modulates excitation-contraction coupling and spontaneous Ca2+ release in normal adult rabbit ventricular cardiomyocytes","volume":"76","author":"Loughrey","year":"2007","journal-title":"Cardiovasc Res"},{"issue":"2","key":"10.1016\/j.jpet.2025.103652_bib19","doi-asserted-by":"crossref","first-page":"126","DOI":"10.2174\/157488409788184972","article-title":"Pharmacological characteristics and clinical applications of K201","volume":"4","author":"Kaneko","year":"2009","journal-title":"Curr Clin Pharmacol"},{"issue":"5","key":"10.1016\/j.jpet.2025.103652_bib20","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/sj.bjp.0707564","article-title":"Effect of K201, a novel antiarrhythmic drug on calcium handling and arrhythmogenic activity of pulmonary vein cardiomyocytes","volume":"153","author":"Chen","year":"2008","journal-title":"Br J Pharmacol"},{"issue":"18","key":"10.1016\/j.jpet.2025.103652_bib21","doi-asserted-by":"crossref","first-page":"3401","DOI":"10.1111\/bph.16379","article-title":"A novel ryanodine receptor 2 inhibitor, M201-A, enhances natriuresis, renal function and lusi-inotropic actions: preclinical and phase I study","volume":"181","author":"Kaneko","year":"2024","journal-title":"Br J Pharmacol"},{"issue":"3","key":"10.1016\/j.jpet.2025.103652_bib22","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1161\/CIRCRESAHA.117.312067","article-title":"MUSCLEMOTION: a versatile open software tool to quantify cardiomyocyte and cardiac muscle contraction in vitro and in vivo","volume":"122","author":"Sala","year":"2018","journal-title":"Circ Res"},{"issue":"10","key":"10.1016\/j.jpet.2025.103652_bib23","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1161\/CIRCRESAHA.107.154609","article-title":"Overexpression of FK-506 binding protein 12.0 modulates excitation contraction coupling in adult rabbit ventricular cardiomyocytes","volume":"101","author":"Seidler","year":"2007","journal-title":"Circ Res"},{"issue":"13","key":"10.1016\/j.jpet.2025.103652_bib24","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.1016\/j.celrep.2018.08.079","article-title":"International multisite study of human-induced pluripotent stem cell-derived cardiomyocytes for drug proarrhythmic potential assessment","volume":"24","author":"Blinova","year":"2018","journal-title":"Cell Rep"},{"issue":"1","key":"10.1016\/j.jpet.2025.103652_bib25","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/toxsci\/kfw200","article-title":"Comprehensive translational assessment of human-induced pluripotent stem cell derived cardiomyocytes for evaluating drug-induced arrhythmias","volume":"155","author":"Blinova","year":"2017","journal-title":"Toxicol Sci"},{"issue":"7","key":"10.1016\/j.jpet.2025.103652_bib26","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1038\/bjp.2008.240","article-title":"Sensitive and reliable proarrhythmia in vivo animal models for predicting drug-induced torsades de pointes in patients with remodelled hearts","volume":"154","author":"Sugiyama","year":"2008","journal-title":"Br J Pharmacol"},{"issue":"17","key":"10.1016\/j.jpet.2025.103652_bib27","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1161\/CIRCULATIONAHA.111.067306","article-title":"Enhanced sarcoplasmic reticulum Ca2+ leak and increased Na+-Ca2+ exchanger function underlie delayed afterdepolarizations in patients with chronic atrial fibrillation","volume":"125","author":"Voigt","year":"2012","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.jpet.2025.103652_bib28","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1161\/CIRCEP.114.001938","article-title":"Catheter ablation of atrial fibrillation in patients with left ventricular systolic dysfunction: a systematic review and meta-analysis","volume":"7","author":"Anselmino","year":"2014","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"25","key":"10.1016\/j.jpet.2025.103652_bib29","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1016\/j.jacc.2020.04.065","article-title":"Recurrence of atrial fibrillation after catheter ablation or antiarrhythmic drug therapy in the CABANA trial","volume":"75","author":"Poole","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.jpet.2025.103652_bib30","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jphs.2024.08.004","article-title":"In vivo cardiovascular profile of ryanodine receptor 2 inhibitor M201-A: utility as an anti-atrial fibrillatory drug for patients suffering from heart failure with preserved ejection fraction","volume":"156","author":"Kambayashi","year":"2024","journal-title":"J Pharmacol Sci"},{"issue":"6A","key":"10.1016\/j.jpet.2025.103652_bib31","doi-asserted-by":"crossref","first-page":"2D","DOI":"10.1016\/S0002-9149(02)03373-8","article-title":"Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy","volume":"91","author":"Maisel","year":"2003","journal-title":"Am J Cardiol"},{"issue":"16","key":"10.1016\/j.jpet.2025.103652_bib32","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1161\/CIRCULATIONAHA.116.026054","article-title":"Treatment of patients with atrial fibrillation and heart failure with reduced ejection fraction","volume":"135","author":"Verma","year":"2017","journal-title":"Circulation"},{"issue":"20","key":"10.1016\/j.jpet.2025.103652_bib33","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1161\/CIRCULATIONAHA.111.019893","article-title":"Atrial fibrillation pathophysiology: implications for management","volume":"124","author":"Iwasaki","year":"2011","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.jpet.2025.103652_bib34","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1113\/JP272883","article-title":"Potassium currents in the heart: functional roles in repolarization, arrhythmia and therapeutics","volume":"595","author":"Chiamvimonvat","year":"2017","journal-title":"J Physiol"},{"issue":"5","key":"10.1016\/j.jpet.2025.103652_bib35","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1093\/bja\/aeh132","article-title":"Is prolongation of the QTc interval during isoflurane anaesthesia more prominent in women pretreated with anthracyclines for breast cancer?","volume":"92","author":"Owczuk","year":"2004","journal-title":"Br J Anaesth"},{"issue":"2","key":"10.1016\/j.jpet.2025.103652_bib36","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1213\/00000539-199102000-00001","article-title":"Prolongation of the QT interval by enflurane, isoflurane, and halothane in humans","volume":"72","author":"Schmeling","year":"1991","journal-title":"Anesth Analg"},{"issue":"2","key":"10.1016\/j.jpet.2025.103652_bib37","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s10840-008-9290-6","article-title":"Efficacy and safety of dofetilide in patients with atrial fibrillation and atrial flutter","volume":"23","author":"Banchs","year":"2008","journal-title":"J Interv Card Electrophysiol"},{"issue":"12","key":"10.1016\/j.jpet.2025.103652_bib38","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1056\/NEJM199909163411201","article-title":"Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group","volume":"341","author":"Torp-Pedersen","year":"1999","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.jpet.2025.103652_bib39","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/0735-1097(96)00121-0","article-title":"Efficacy of intravenous ibutilide for rapid termination of atrial fibrillation and atrial flutter: a dose-response study","volume":"28","author":"Ellenbogen","year":"1996","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.jpet.2025.103652_bib40","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1161\/01.CIR.81.2.686","article-title":"Class III antiarrhythmic agents have a lot of potential but a long way to go. Reduced effectiveness and dangers of reverse use dependence","volume":"81","author":"Hondeghem","year":"1990","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.jpet.2025.103652_bib41","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s00395-021-00900-9","article-title":"Cardiomyocyte Na+ and Ca2+ mishandling drives vicious cycle involving CaMKII, ROS, and ryanodine receptors","volume":"116","author":"Hegyi","year":"2021","journal-title":"Basic Res Cardiol"},{"issue":"5","key":"10.1016\/j.jpet.2025.103652_bib42","article-title":"Effects of K201\u2019s metabolite, M-II, on atrial flutter and fibrillation; simultaneous multisite mapping studies in the canine sterile pericarditis model","volume":"8","author":"Sadrpour","year":"2011","journal-title":"Heart Rhythm"},{"issue":"5","key":"10.1016\/j.jpet.2025.103652_bib43","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1097\/FJC.0000000000000219","article-title":"Termination of atrial flutter and fibrillation by K201\u2019s metabolite M-II: studies in the canine sterile pericarditis model","volume":"65","author":"Sadrpour","year":"2015","journal-title":"J Cardiovasc Pharmacol"},{"issue":"8","key":"10.1016\/j.jpet.2025.103652_bib44","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1172\/JCI46315","article-title":"Recent advances in the molecular pathophysiology of atrial fibrillation","volume":"121","author":"Wakili","year":"2011","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.jpet.2025.103652_bib45","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1161\/01.CIR.0000044917.74408.BE","article-title":"FKBP12.6-mediated stabilization of calcium-release channel (ryanodine receptor) as a novel therapeutic strategy against heart failure","volume":"107","author":"Yano","year":"2003","journal-title":"Circulation"},{"issue":"21","key":"10.1016\/j.jpet.2025.103652_bib46","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1001\/jama.1993.03510210076031","article-title":"Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs","volume":"270","author":"Makkar","year":"1993","journal-title":"JAMA"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356525398654?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356525398654?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T22:32:19Z","timestamp":1762209139000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356525398654"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":46,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S0022356525398654"],"URL":"https:\/\/doi.org\/10.1016\/j.jpet.2025.103652","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological study of the safety, efficacy, and potential of M201-A on paroxysmal and persistent atrial fibrillation","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpet.2025.103652","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of American Society for Pharmacology and Experimental Therapeutics.","name":"copyright","label":"Copyright"}],"article-number":"103652"}}